United Bank Vista Gen Therapeutics, Inc. Transaction History

United Bank

  • $857 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.14 - $4.8 $2,511 - $86,112
-17,940 Reduced 47.29%
20,000 $3,000
Q2 2022

Aug 12, 2022
BUY
$0.88 - $1.73 $33,387 - $65,636
37,940 New
37,940 $33,000

Others Institutions Holding VTGN

# of Institutions
1
Shares Held
27.1K
Call Options Held
0
Put Options Held
0
View Full List

About VistaGen Therapeutics, Inc.

VTGN Quotes by TradingView
  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $610M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track United Bank Portfolio

Follow United Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Bank, based on Form 13F filings with the SEC.

News

Stay updated on United Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email